Muhlenkamp & CO Inc Lannett CO Inc Transaction History

Muhlenkamp & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$4.75 - $14.5 $1.29 Million - $3.95 Million	-272,442 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$13.3 - $17.45 $2,407 - $3,158	-181 Reduced 0.07%	272,442 $3.71 Million
Q1 2018 May 11, 2018	SELL	$14.7 - $24.95 $2.36 Million - $4 Million	-160,511 Reduced 37.06%	272,623 $0
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $432,606 - $635,865	-21,739 Reduced 4.78%	433,134 $10 Million
Q3 2017 Nov 13, 2017	SELL	$15.1 - $19.25 $470,923 - $600,349	-31,187 Reduced 6.42%	454,873 $8.39 Million
Q2 2017 Aug 11, 2017	BUY	N/A	486,060	486,060 $9.92 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Muhlenkamp & CO Inc with notifications on news.